Drug interactions
Deferoxamine + Exagamglogene autotemcel
Severity: Major
Deferoxamine and Exagamglogene autotemcel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Iron chelators may impair marrow recovery and engraftment around mobilization and myeloablative conditioning for this gene therapy. Labeling advises stopping chelation beforehand.
What this interaction means in plain words
Deferoxamine and Exagamglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Deferoxamine belongs to Miscellaneous; Exagamglogene autotemcel belongs to Miscellaneous.
Why it happens
Possible interference with hematopoietic recovery; the precise mechanism is not established.
What to do
Discontinue iron chelators at least 7 days before mobilization and conditioning. Use phlebotomy if iron reduction is needed during this period, as clinically appropriate.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Deferoxamine and Exagamglogene autotemcel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Deferoxamine
Other interactions of Exagamglogene autotemcel
Frequently asked questions
Can I take Deferoxamine with Exagamglogene autotemcel?
MediHelp rates the interaction as major. Deferoxamine and Exagamglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Iron chelators may impair marrow recovery and engraftment around mobilization and myeloablative conditioning for this gene therapy. Labeling advises stopping chelation beforehand.
How serious is the interaction between Deferoxamine and Exagamglogene autotemcel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue iron chelators at least 7 days before mobilization and conditioning. Use phlebotomy if iron reduction is needed during this period, as clinically appropriate.
What other medicines interact with Deferoxamine?
MediHelp also lists interactions of Deferoxamine with, for example, Ascorbic acid, Betibeglogene autotemcel, Lovotibeglogene autotemcel. The full list is on the Deferoxamine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
